Phosphodiesterase-5 gene (PDE5A) polymorphisms are associated with progression of childhood IgA nephropathy

Pediatric Nephrology

Volumn 25, Issue 9, 2010, Pages 1663-1671

  Hahn, Won Ho ^a   Suh, Jin Soon ^a   Cho, Byoung Soo ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Childhood; IgA nephropathy; Phosphodiesterase 5A; Polymorphism

Indexed keywords

PHOSPHODIESTERASE V; PDE5A PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CODOMINANCE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE MAPPING; GENOTYPE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; NEPHROSIS; PODOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEINURIA; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; CASE CONTROL STUDY; CELL PROLIFERATION; DOMINANT GENE; ENZYMOLOGY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; MESANGIUM CELL; MIDDLE AGED; NEPHROTIC SYNDROME; PATHOLOGY; PHENOTYPE; RISK; RISK ASSESSMENT; SOUTH KOREA; STATISTICAL MODEL; TIME;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CELL PROLIFERATION; CHILD; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENES, DOMINANT; GENETIC PREDISPOSITION TO DISEASE; GLOMERULONEPHRITIS, IGA; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MESANGIAL CELLS; MIDDLE AGED; NEPHROTIC SYNDROME; ODDS RATIO; PHENOTYPE; PODOCYTES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINURIA; REPUBLIC OF KOREA; RISK ASSESSMENT; TIME FACTORS;

EID: 77955013784     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-010-1579-x     Document Type: Article

References (36)

1. AB Fogo 2007 Mechanisms of progression of chronic kidney disease Pediatr Nephrol 22 2011 2022 10.1007/s00467-007-0524-0 17647026 (Pubitemid 50001040)
2. J Barratt AC Smith K Molyneux J Feehally 2007 Immunopathogenesis of IgAN Semin Immunopathol 29 427 443 10.1007/s00281-007-0089-9 1:CAS:528: DC%2BD2sXht1OksbvE 17851660 (Pubitemid 350077260)
3. B Hohenstein C Daniel S Wittmann C Hugo 2008 PDE-5 inhibition impedes TSP-1 expression, TGF-beta activation and matrix accumulation in experimental glomerulonephritis Nephrol Dial Transplant 23 3427 3436 10.1093/ndt/gfn319 1:CAS:528:DC%2BD1cXht1OitrzI 18596129
4. J Kotera K Fujishige K Omori 2000 Immunohistochemical localization of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in rat tissues J Histochem Cytochem 48 685 693 1:CAS:528:DC%2BD3cXivFyntr8%3D 10769052
5. S Knight H Snellen M Humphreys C Baylis 2007 Increased renal phosphodiesterase-5 activity mediates the blunted natriuretic response to ANP in the pregnant rat Am J Physiol Renal Physiol 292 F655 F659 10.1152/ajprenal. 00309.2006 1:CAS:528:DC%2BD2sXjt1Gmtr8%3D 17003222 (Pubitemid 46220533)
6. B Rodriguez-Iturbe A Ferrebuz V Vanegas Y Quiroz F Espinoza H Pons ND Vaziri 2005 Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage Kidney Int 68 2131 2142 10.1111/j.1523-1755.2005. 00669.x 1:CAS:528:DC%2BD2MXht1SgtbbO 16221212 (Pubitemid 43117787)
7. KW Lee JY Jeong BJ Lim YK Chang SJ Lee KR Na YT Shin DE Choi 2009 Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity Toxicology 257 137 143 10.1016/j.tox.2008.12. 017 1:CAS:528:DC%2BD1MXit1Ogt70%3D 19152827
8. N Hosogai M Tomita K Hamada T Ogawa J Hirosumi T Manda S Mutoh 2003 Phosphodiesterase type 5 inhibition ameliorates nephrotoxicity induced by cyclosporin A in spontaneous hypertensive rats Eur J Pharmacol 477 171 178 10.1016/j.ejphar.2003.08.014 1:CAS:528:DC%2BD3sXnslSrsrg%3D 14519421 (Pubitemid 38373534)
9. A Furusu M Miyazaki K Abe S Tsukasaki K Shioshita O Sasaki K Miyazaki Y Ozono T Koji T Harada H Sakai S Kohno 1998 Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis Kidney Int 53 1760 1768 10.1046/j.1523-1755.1998.00907.x 1:STN:280:DyaK1c3ntVWgsQ%3D%3D 9607210 (Pubitemid 28243762)
10. A Kashem M Endoh N Yano F Yamauchi Y Nomoto H Sakai 1996 Expression of inducible-NOS in human glomerulonephritis: the possible source is infiltrating monocytes/macrophages Kidney Int 50 392 399 10.1038/ki.1996.328 1:STN:280:DyaK28vjslKiug%3D%3D 8840265
11. LQ Qiu R Sinniah SI Hsu 2004 Coupled induction of iNOS and p53 upregulation in renal resident cells may be linked with apoptotic activity in the pathogenesis of progressive IgA nephropathy J Am Soc Nephrol 15 2066 2078 10.1097/01.ASN.0000133532.99109.3D 1:CAS:528:DC%2BD2cXlvVKmu7s%3D 15284293 (Pubitemid 39031346)
12. M Merta J Reiterova V Tesar J Stekrova O Viklicky 2002 Influence of the endothelial nitric oxide synthase polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy Ren Fail 24 585 593 10.1081/JDI-120013961 1:CAS:528:DC%2BD38XotlOjsL0%3D 12380903
13. T Morita H Ito T Suehiro K Tahara A Matsumori H Chikazawa Y Nakauchi K Nishiya K Hashimoto 1999 Effect of a polymorphism of endothelial nitric oxide synthase gene in Japanese patients with IgA nephropathy Clin Nephrol 52 203 209 1:CAS:528:DyaK1MXmsVKiur4%3D 10543322
14. M Burg J Menne T Ostendorf V Kliem J Floege 1997 Gene-polymorphisms of angiotensin converting enzyme and endothelial nitric oxide synthase in patients with primary glomerulonephritis Clin Nephrol 48 205 211 1:CAS:528: DyaK2sXmslSqs70%3D 9352153
15. Q Hong R Ding XM Chen Y Lu 2006 Association between endothelial nitric oxide synthase gene 4a/b polymorphism and IgA nephropathy Nan Fang Yi Ke Da Xue Xue Bao 26 1421-1422 1430
16. B Alasehirli A Balat O Barlas A Kont 2009 Nitric oxide synthase gene polymorphisms in children with minimal change nephrotic syndrome Pediatr Int 51 75 78 10.1111/j.1442-200X.2008.02655.x 1:CAS:528:DC%2BD1MXktFGmsrk%3D 19371282
17. W Kim SK Kang DY Lee GY Koh KY Lee SK Park 2000 Endothelial nitric oxide synthase gene polymorphism in patients with IgA nephropathy Nephron 86 232 233 10.1159/000045765 1:CAS:528:DC%2BD3cXns1Gisrk%3D 11015016
18. SC Lim JJ Liu HQ Low NG Morgenthaler Y Li LY Yeoh YS Wu SK Goh CY Chionh SH Tan YC Kon PC Soon YM Bee T Subramaniam CF Sum KS Chia 2009 Microarray analysis of multiple candidate genes and associated plasma proteins for nephropathy secondary to type 2 diabetes among Chinese individuals Diabetologia 52 1343 1351 10.1007/s00125-009-1368-x 1:CAS:528:DC%2BD1MXms1yhsrw%3D 19415232
19. JC Rodriguez-Perez A Macias-Reyes A Jimenez-Sosa O Companioni FJ Rodriguez-Esparragon MA Cobo MD Checa-Andres L Palop-Cubillo A Alonso A Torres 2009 A synergistic association of ACE I/D and eNOS G894T gene variants with the progression of immunoglobulin a nephropathy-a pilot study Am J Nephrol 30 303 309 10.1159/000225938 1:CAS:528:DC%2BD1MXhtFaksL7F 19546528
20. F Salvi R Sarzani R Giorgi G Donatelli F Pietrucci A Micheli M Baldoni D Minardi P Dessi-Fulgheri M Polito G Muzzonigro A Rappelli 2004 Cardiovascular effects of sildenafil in hypertensive men with erectile dysfunction and different alleles of the type 5 cGMP-specific phosphodiesterase (PDE5) Int J Impot Res 16 412 417 10.1038/sj.ijir.3901246 1:CAS:528:DC%2BD2cXot1Ckt7Y%3D 15175637 (Pubitemid 39319040)
21. HS Lee MS Lee SM Lee SY Lee ES Lee EY Lee SY Park JS Han S Kim JS Lee 2005 Histological grading of IgA nephropathy predicting renal outcome: revisiting H.S. Lee's glomerular grading system Nephrol Dial Transplant 20 342 348 10.1093/ndt/gfh633 15618239 (Pubitemid 40276890)
22. SB Gabriel SF Schaffner H Nguyen JM Moore J Roy B Blumenstiel J Higgins M DeFelice A Lochner M Faggart SN Liu-Cordero C Rotimi A Adeyemo R Cooper R Ward ES Lander MJ Daly D Altshuler 2002 The structure of haplotype blocks in the human genome Science 296 2225 2229 10.1126/science.1069424 1:CAS:528: DC%2BD38XkvFGhtrc%3D 12029063 (Pubitemid 34680308)
23. Y Zhu J Yao Y Meng A Kasai N Hiramatsu K Hayakawa T Miida M Takeda M Okada M Kitamura 2006 Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system Br J Pharmacol 148 833 844 10.1038/sj.bjp.0706785 1:CAS:528:DC%2BD28XmvFamtrs%3D 16751794 (Pubitemid 44079413)
24. DE Choi JY Jeong BJ Lim S Chung YK Chang SJ Lee KR Na SY Kim YT Shin KW Lee 2009 Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats Am J Physiol Renal Physiol 297 F362 370 10.1152/ajprenal.90609.2008 1:CAS:528:DC%2BD1MXhtVaht7rP 19474186
25. DH Lau DP Mikhailidis CS Thompson 2007 The effect of vardenafil (a PDE type 5 inhibitor) on renal function in the diabetic rabbit: a pilot study In Vivo 21 851 854 1:CAS:528:DC%2BD2sXhtlaqsr7J 18019423
26. YJ Chiu IA Reid 2002 Effect of sildenafil on renin secretion in human subjects Exp Biol Med (Maywood) 227 620 625 1:CAS:528:DC%2BD38XmsFaksrk%3D
27. HC Thiesson BL Jensen B Jespersen OB Schaffalitzky de Muckadell C Bistrup S Walter PD Ottosen A Veje O Skott 2005 Inhibition of cGMP-specific phosphodiesterase type 5 reduces sodium excretion and arterial blood pressure in patients with NaCl retention and ascites Am J Physiol Renal Physiol 288 F1044 F1052 10.1152/ajprenal.00142.2004 1:CAS:528:DC%2BD2MXktlSgtL8%3D 15613622 (Pubitemid 40569770)
28. B Conne A Stutz JD Vassalli 2000 The 3′ untranslated region of messenger RNA: a molecular 'hotspot' for pathology? Nat Med 6 637 641 10.1038/76211 1:CAS:528:DC%2BD3cXkt12juro%3D 10835679 (Pubitemid 30398786)
29. TA Hughes 2006 Regulation of gene expression by alternative untranslated regions Trends Genet 22 119 122 10.1016/j.tig.2006.01.001 1:CAS:528: DC%2BD28XhvVWit74%3D 16430990 (Pubitemid 43290014)
30. PH Olsen V Ambros 1999 The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation Dev Biol 216 671 680 10.1006/dbio.1999.9523 1:CAS:528:DC%2BD3cXltFyqtA%3D%3D 10642801 (Pubitemid 30013313)
31. AA Komar 2007 Silent SNPs: impact on gene function and phenotype Pharmacogenomics 8 1075 1080 10.2217/14622416.8.8.1075 1:CAS:528: DC%2BD2sXpsFKlsrc%3D 17716239 (Pubitemid 47423694)
32. C Kimchi-Sarfaty JM Oh IW Kim ZE Sauna AM Calcagno SV Ambudkar MM Gottesman 2007 A "silent" polymorphism in the MDR1 gene changes substrate specificity Science 315 525 528 10.1126/science.1135308 1:CAS:528:DC%2BD2sXotFCitA%3D%3D 17185560 (Pubitemid 46175758)
33. SY Ying CP Chang SL Lin 2010 Intron-mediated RNA interference, intronic microRNAs, and applications Methods Mol Biol 629 205 237 10.1007/978-1-60761- 657-3-14 20387152
34. EJ Malisic RN Jankovic SS Radulovic 2010 An intronic variant in the TP53 gene in Serbian women with cervical or ovarian cancer Cancer Genet Cytogenet 198 173 175 10.1016/j.cancergencyto.2010.01.006 1:CAS:528:DC%2BC3cXktlGjur0%3D 20362235
35. K Maruyama M Yoshida H Nishio T Shirakawa T Kawamura R Tanaka H Nakamura K Iijima N Yoshikawa 2001 Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy Pediatr Nephrol 16 350 355 10.1007/s004670000555 1:STN:280:DC%2BD3M3lsFegsg%3D%3D 11354780 (Pubitemid 32366670)
36. K Nakanishi M Sako N Yata N Aoyagi K Nozu R Tanaka K Iijima N Yoshikawa 2004 A-20C angiotensinogen gene polymorphism and proteinuria in childhood IgA nephropathy Pediatr Nephrol 19 144 147 10.1007/s00467-003-1350-7 14648325 (Pubitemid 38181004)